Science News About Research Funding

NIH is funding a first-of-its-kind community-led research program to study ways to address the underlying structural factors within communities that affect health, such as access to safe spaces, healthy food, employment opportunities, transportation, and quality health care.

The National Institutes of Health (NIH) is pleased to announce the winners of 2022 Speaking Up About Mental Health! This Is My Story essay contest.

The National Institutes of Health has launched two transformative projects supported by the Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative: The BRAIN Initiative® Cell Atlas Network and the Armamentarium for Precision Brain Cell Access.

The National Institute of Mental Health has appointed Christina P.C. Borba, Ph.D., M.P.H., as director of the Office for Disparities Research and Workforce Diversity (ODWD). She began her new role on September 6, 2022.

The National Institutes of Health has awarded a total of $100 million over the next five years to support nine Autism Centers of Excellence. This endeavor funds large research projects to understand and develop interventions for autism spectrum disorder.

The newly launched Bespoke Gene Therapy Consortium (BGTC), part of the NIH Accelerating Medicines Partnership (AMP) program, aims to optimize and streamline the gene therapy development process to help fill the unmet medical needs of people with rare diseases.

The NIH Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative Cell Census Network (BICCN) has unveiled an atlas of cell types and an anatomical neuronal wiring diagram for the mammalian primary motor cortex, derived from detailed studies of mice, monkeys, and humans.

NIMH is working to meet the urgent need for rapid-acting suicide prevention interventions by supporting research investigating the feasibility and safety of treatment protocols that have the potential to quickly reduce severe suicide risk in youth and adults.

Andrea Beckel-Mitchener, Ph.D., has been named deputy director of the trans-NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative.

In this statement, NIMH Director Dr. Joshua Gordon reaffirms his commitment to dismantling structural racism in biomedical research and describes next steps for NIMH.

The Early Psychosis Intervention Network (EPINET), an NIMH initiative aimed at determining how to best provide treatment for individuals experiencing symptoms of early psychosis, is increasing access to resources for researchers, providers, and families through a growing network of research hubs and a new website.

NIMH, along with other NIH Institutes, is supporting the ABC-CT project, a multisite study that aims to test and refine biomarkers that can be used as objective measures of social impairment for children with autism in clinical trials, leading to more predictive and personalized treatment.

Suicide attempts by firearm are especially dangerous, with as many as 9 out of 10 attempts resulting in death. NIMH is supporting three projects focused on preventing and reducing firearm injury and mortality to help address the critical need for more research in this area.

NIMH has joined with other NIH Institutes in launching an new Accelerating Medicines Partnership focused on advancing the development of better ways to identify and treat those at clinical high risk for psychosis.

In a new paper, published in JAMA Psychiatry, NIMH looks forward, outlining the next stages in the Institute’s suicide prevention research priorities.

Right now, people across the country are currently coping with yet another episode of violence perpetrated against a person of color. In this Institute Update, Dr. Gordon addresses recent events.

NIMH, along with other NIH Institutes, is supporting the goal of identifying autism in the first year of life by funding projects that seek to seek to translate findings related to early-emerging signs of autism into practical ASD screening tools that can be implemented in the general population and community settings.

In 2018, 11.4 million adults in the United States experienced a serious mental illness, such as schizophrenia-spectrum disorders, severe bipolar disorder, and severe depression.

The National Institutes of Health (NIH) has awarded more than four million dollars in FY 2019 to support seven research projects aimed at developing and validating screening tools to detect signs of autism spectrum disorder in the first year of life.

The NIH has announced its continued support for the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative by funding more than 180 new BRAIN Initiative awards, bringing the total 2019 budget for the program to more than $424 million.

NIMH awarded six research grants for studies to develop a learning health care system for the treatment of early psychosis.

The National Institute of Mental Health (NIMH) recently developed a Clinical Research Toolbox designed to assist clinical investigators with the development of clinical research studies.

A trainee tells her story of how NIMH/NIH training programs for members of underrepresented groups have nurtured her scientific career.

National Institute of Mental Health (NIMH) recently released its second annual update of the Strategic Research Priorities.

Two biological engineering researchers are winners in Phase 2 of NIH’s Follow that Cell Challenge. The winners will share $400,000 in prizes awarded for development of new tools and methods for predicting the behavior and function of a single cell in complex tissue over time – and how that reflects the health of the tissue.

By carefully tracking 5,000 people after they have experienced a traumatic event, a just-launched NIMH-funded study aims to provide a finely detailed map of the array of factors that play a role in the development of mental disorders that occur in the wake of trauma.

National Institute of Mental Health (NIMH) recently released updates to its Strategic Research Priorities.

NIMH is supporting Zero Suicide efforts with 3 new research grants. Each project focuses on prevention and health care systems.

New research shows that a team-based, coordinated specialty care treatment plan produces better outcomes than typical community care for people with first episode psychosis. Investigators also found that treatment is most effective for people who receive care soon after psychotic symptoms begin.

NIMH, NIH, and the National Institute of Justice are collaborating on a 4-year, $6.8 million study called Suicide Prevention for at-Risk Individuals in Transition or “SPIRIT.” The study focuses on the high-risk individuals who are transitioning from jail to community. SPIRIT is NIMH’s first major investment in suicide prevention in the justice system.

James McPartland, Ph.D. of Yale University will lead a new four-year $28 million Biomarkers Consortium project that aims to improve clinical evaluation of treatments for social impairment in children with autism.

New NIMH Strategic Plan balances the need for long-term investments in basic research with urgent mental health needs.

Dr. Sarah Hollingsworth Lisanby, one of the leading researchers in the area of neuromodulatory interventions for treating major depression, will join NIMH as the director of the Division of Translational Research.

NIMH announces a new unit within the Office of the Director to support the development of the institute’s Research Domain Criteria initiative. The unit will enhance communication with scientists, clinicians, and the public to refine the RDoC research framework and accelerate the translation of basic research into clinical treatments.

NIH-funded projects aim at improving access, timeliness of interventions.